Lass-Flörl, C.; Krause, R.; Willinger, B.; Starzengruber, P.; Decristoforo, P.; Neururer, S.; Kreidl, P.; Aigner, M.
Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study. J. Fungi 2020, 6, 76.
https://doi.org/10.3390/jof6020076
AMA Style
Lass-Flörl C, Krause R, Willinger B, Starzengruber P, Decristoforo P, Neururer S, Kreidl P, Aigner M.
Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study. Journal of Fungi. 2020; 6(2):76.
https://doi.org/10.3390/jof6020076
Chicago/Turabian Style
Lass-Flörl, Cornelia, Robert Krause, Birgit Willinger, Peter Starzengruber, Petra Decristoforo, Sabrina Neururer, Peter Kreidl, and Maria Aigner.
2020. "Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study" Journal of Fungi 6, no. 2: 76.
https://doi.org/10.3390/jof6020076
APA Style
Lass-Flörl, C., Krause, R., Willinger, B., Starzengruber, P., Decristoforo, P., Neururer, S., Kreidl, P., & Aigner, M.
(2020). Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study. Journal of Fungi, 6(2), 76.
https://doi.org/10.3390/jof6020076